Sandra Von Meier PhDDirector Oncology Licensing & Business Development at Merck
Sandra joined Merck in 2014 as Director Business Development Oncology. During her 6 years within Business Development she led numerous transactions, evaluations and due diligences, supporting the transformation of Merck Healthcare KGaA into a leading global oncology company. Before Merck, Sandra was leading the Business Development activities at Medigene, a publicly listed German biotechnology company where she also closed several oncology transactions. Sandra studied Biochemistry at the FU Berlin and then moved to London in 1995 for her Diploma at the Institute of Cancer Research. In 1996 she was awarded a joint PhD scholarship from the Ludwig Institute for Cancer Research in London in collaboration with GlaxoSmithKline in Stevenage, UK. Sandra received her PhD from University College London in 1999.